Evoke Pharma
EVOK
EVOK
12 hedge funds and large institutions have $228K invested in Evoke Pharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
77% less capital invested
Capital invested by funds: $987K → $228K (-$759K)
Holders
12
Holding in Top 10
–
Calls
$39K
Puts
$17K
Top Buyers
| 1 | +$12.1K | |
| 2 | +$7.43K | |
| 3 | +$5K | |
| 4 |
Citigroup
New York
|
+$3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$2K |
Top Sellers
| 1 | -$201K | |
| 2 | -$54K | |
| 3 | -$41K | |
| 4 |
CC
Cornerstone Capital
Palo Alto,
California
|
-$33K |
| 5 |
BlackRock
New York
|
-$21.2K |